The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 333:603 August 31, 1995 Number 9
NextNext

The Fibromyalgia Syndrome: Current research and future directions in epidemiology, pathogenesis, and treatment

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Stanley R. Pillemer. 184 pp. Binghamton, N.Y., Haworth Press, 1995. $29.95. ISBN 1-56024-714-2.

Thirty years have elapsed since C.K. Meador proposed the concept of nondisease in the Journal ("The Art and Science of Nondisease." 1965;272:92-5). He suggested that when a specific disease is suspected but not found, the patient has a particular nondisease. Fibromyalgia has enjoyed the reputation of being a nondisease for many years. Known as fibrositis until Yunus correctly renamed it in 1980 because the process was noninflammatory, fibromyalgia has evolved from being a closet rheumatologic syndrome that everybody studied for five minutes in medical school to one of the "fad" diseases of the 1990s that embraces components of chronic fatigue . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.